Overcoming asset transfer challenges during a merger and acquisition (M&A)

In this video, Parexel’s Paul Bridges, Worldwide Head of Regulatory & Access, speaks with Phil Smith, Vice President, Regulatory Outsourcing about how pharma and biotech can overcome common operational challenges and key considerations for a more successful asset transfer.

Previous Video
Where is Long COVID Research Going
Where is Long COVID Research Going

Next Video
Managing Clinical Trial Complexity: The future is Collaborative
Managing Clinical Trial Complexity: The future is Collaborative

Alongside other industry experts Parexel’s Sy Pretorius, President, Clinical Development & Chief Medical Of...